(Q48500250)

12 February 2018

review article

1 reference

title

Examining the utility of patient-derived xenograft mouse models. (English)

1 reference

12 February 2018

1 reference

1 reference

2

1 reference

12 February 2018

Andrew L. Kung

series ordinal

3

1 reference

12 February 2018

Samuel Aparicio

series ordinal

1

object named as

Samuel Aparicio

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 May 2015

1 reference

12 February 2018

published in

Nature Reviews Cancer

1 reference

12 February 2018

volume

15

1 reference

12 February 2018

page(s)

311-316

1 reference

12 February 2018

issue

5

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/nrc3944

exact match

0 references

cites work

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

1 reference

A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models

31 March 2020

1 reference

Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma

31 March 2020

1 reference

Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity

31 March 2020

1 reference

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

31 March 2020

1 reference

Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.

31 March 2020

1 reference

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

31 March 2020

1 reference

PyClone: statistical inference of clonal population structure in cancer.

31 March 2020

1 reference

Genome remodelling in a basal-like breast cancer metastasis and xenograft

31 March 2020

1 reference

Patient-derived xenograft models: an emerging platform for translational cancer research

31 March 2020

1 reference

Molecular profiling of patient-derived breast cancer xenografts

31 March 2020

1 reference

Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer.

31 March 2020

1 reference

Transcriptional dissection of pancreatic tumors engrafted in mice.

31 March 2020

1 reference

Practices and pitfalls of mouse cancer models in drug discovery.

31 March 2020

1 reference

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

31 March 2020

1 reference

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer

31 March 2020

1 reference

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

31 March 2020

1 reference

Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

31 March 2020

1 reference

A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma

31 March 2020

1 reference

Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer

31 March 2020

1 reference

Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development

31 March 2020

1 reference

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer

31 March 2020

1 reference

Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft

31 March 2020

1 reference

Patient-derived models of acquired resistance can identify effective drug combinations for cancer.

31 March 2020

1 reference

Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer

31 March 2020

1 reference

Organoid models of human and mouse ductal pancreatic cancer

31 March 2020

1 reference

Organoid cultures derived from patients with advanced prostate cancer

31 March 2020

1 reference

Identification of multipotent luminal progenitor cells in human prostate organoid cultures

31 March 2020

1 reference

Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture

31 March 2020

1 reference

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

31 March 2020

1 reference

Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancer

31 March 2020

1 reference

A model for personalized in vivo analysis of human immune responsiveness

31 March 2020

1 reference

Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer

31 March 2020

1 reference

Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity

31 March 2020

1 reference

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

31 March 2020

1 reference

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

31 March 2020

1 reference

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial

31 March 2020

1 reference

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

31 March 2020

1 reference

Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance

31 March 2020

1 reference

Preclinical testing of antileukemic drugs using an in vivo model of systemic disease

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25907221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25907221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25907221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRC3944

1 reference

12 February 2018

PubMed ID

25907221

1 reference

12 February 2018